Pfizer Builds on the Genedata Biopharma E2E Workflow Platform

After an aborted attempt with a develop-as-you-go approach, Pfizer chose the Genedata platform to serve as a central data backbone and application environment upon which they could build tools to flexibly address Pfizer-specific requirements and to drive innovation. In use since 2015,  the system is used by hundreds of people at 6 Pfizer R&D sites around the globe and supports 500+ distinct projects across therapeutic antibodies and RNAs